Search reports.
Atopic Dermatitis Treatment Market Size, Share & Trends 2030
Get free sample report Request for Customiztion Buy Now

Atopic Dermatitis Treatment Market Size, Share & Trends 2030

Segments - Global Atopic Dermatitis Treatment Market by Mode of Administration (Topical, Orals, and Injectables), Drug Class (Corticosteroids, Antihistamines, Calcineurin Inhibitors, Immunosuppressant, PDE-4 Inhibitor, Antibiotics, Biologic Therapy, and Emollients),Distribution Channel (Retail Pharmacies, Drug Stores, Hospital Pharmacies, Mail Order Pharmacies, Online Pharmacies, and Dermatology Clinics), and Region (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2021-2028

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-4455 | 4.6 Rating | 73 Reviews | 165 Pages | Format : PDF Excel PPT

Report Description


The global atopic dermatitis treatment market is anticipated to expand at a CAGR of 13.1% during the forecast period, between 2021 and 2028. The market growth is attributed to the increasing prevalence of atopic dermatitis.

Atopic dermatitis is an unceasing inflammatory disease of the skin and has a high incidence in kids with 85% of cases near five years of age. While the situation may occur at any age, it usually starts in childhood, with altering brutality over the years. As children age, the region under the knees and elbows are most generally affected.

In adults, the hands and feet are most usually affected. Scratching the affected area deteriorates the indications, and those affected have an increased risk of skin infections. Most people with atopic dermatitis usually develop a high fever or asthma. Its symptoms include red inflamed rash, flare-ups of itch, and excessive dryness of the skin. The cause of atopic dermatitis engages genetic disorders, immune system malfunctioning, difficulty in the permeability of the skin, and environmental exposure.

Atopic Dermatitis Treatment Market key takeaways

  • Large patient population pool and launch of new products are major drivers of the market growth.
  • Initiation of biologics for the treatment of moderate and severe disease is boosting the uptake of topical calcineurin inhibitors and systematic therapies in the rapid growing markets.
  • Severe government guidelines for product approvals can restrain the market growth
  • High cost of uptake of generic topical drugs, biologic therapy, and pediatric population can inhibit the market growth.
  • The advancements and development in healthcare in developing countries are likely to offer new opportunities during the forecast period.

Scope of Atopic Dermatitis Treatment Market report:

The market report includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Atopic Dermatitis Treatment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018 & 2019

Forecast Period

2021–2028

Segmentation

Mode of Administration (Topical, Orals, and Injectables), Drug Class (Corticosteroids, Antihistamines, Calcineurin Inhibitors, Immunosuppressant, PDE-4 Inhibitor, Antibiotics, Biologic Therapy, and Emollients), and Distribution Channel (Retail Pharmacies, Drug Stores, Hospital Pharmacies, Mail Order Pharmacies, Online Pharmacies, and Dermatology Clinics)

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast

Key Players Covered

Sanofi SA, Allergan Plc., Novartis International AG, Bristol-Myers Squibb, Bayer AG, Meda Pharmaceuticals, Anacor Pharmaceutical Inc., Pfizer, Astellas Pharma Inc., and Regeneron Pharmaceuticals

 

Atopic Dermatitis Treatment Market Segment Insights :

In terms of mode of administration, the topic dermatitis treatment market can be divided into topical, oral, and injectable. The topical segment is expected to hold a substantial market share, owing to the growing support from public organizations for managing all the operations in clinics and hospitals to provide effective treatment procedures.

Atopic Dermatitis Treatment Market modes of administration

Based on drug class, the market can be segmented into corticosteroids, antihistamines, calcineurin inhibitors, immunosuppressant, PDE-4 inhibitor, antibiotics, biologic therapy, and emollients. The corticosteroids segment is projected to register a considerable CAGR during the forecast period, as they are often recommended as first-line therapy for the moderate-severe disease. Also, corticosteroids are utilized as pain relief medication for swelling in the body.

On the basis of distribution channel, the atopic dermatitis treatment market can be divided into retail pharmacies, drug stores, hospital pharmacies, mail order pharmacies, online pharmacies, and dermatology clinics. The hospital pharmacies segment is expected to register a robust growth rate during the forecast period, owing to a huge part of the patient population preferring hospitals for the treatment of the disease and usually buying medicines from hospital pharmacies owing to the availability of drugs.

Based on region, the atopic dermatitis treatment market can be fragmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to dominate the market during the projection period, owing to high treatment awareness among the patient population across the US and Canada, early adoption of novel medications, healthcare infrastructure, better settlement policies, and rising business partnerships of pharmaceutical companies with contract research organizations.

Atopic Dermatitis Treatment Market by regions

Segments

By Mode of Administration
  • Topical
  • Orals
  • Injectables
By Drug Class
  • Corticosteroids
  • Antihistamines
  • Calcineurin Inhibitors
  • Immunosuppressant
  • PDE-4 Inhibitor
  • Antibiotics
  • Biologic Therapy
  • Emollients
By Distribution Channel
  • Retail Pharmacies
  • Drug Stores
  • Hospital Pharmacies
  • Mail Order Pharmacies
  • Online Pharmacies
  • Dermatology Clinics
By Region
  • Asia Pacific
  • North America
  • Europe
  • Latin America
  • Middle East & Africa
By Key Players
  • Sanofi SA
  • Allergan Plc
  • Novartis International AG
  • Bristol-Myers Squibb
  • Bayer AG
  • Meda Pharmaceuticals
  • Anacor Pharmaceutical Inc.
  • Pfizer
  • Astellas Pharma Inc.
  • Regeneron Pharmaceuticals

Competitive Landscape

Key players in the atopic dermatitis treatment market includeSanofi SA, Allergan Plc., Novartis International AG, Bristol-Myers Squibb, Bayer AG, Meda Pharmaceuticals, Anacor Pharmaceutical Inc., Pfizer, Astellas Pharma Inc., and Regeneron Pharmaceuticals. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Atopic Dermatitis Treatment Market by key players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Atopic Dermatitis Treatment Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Atopic Dermatitis Treatment Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Atopic Dermatitis Treatment Market - Supply Chain
  4.5. Global Atopic Dermatitis Treatment Market Forecast
     4.5.1. Atopic Dermatitis Treatment Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Atopic Dermatitis Treatment Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Atopic Dermatitis Treatment Market Absolute $ Opportunity
5. Global Atopic Dermatitis Treatment Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Atopic Dermatitis Treatment Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Atopic Dermatitis Treatment Demand Share Forecast, 2019-2026
6. North America Atopic Dermatitis Treatment Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Atopic Dermatitis Treatment Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Atopic Dermatitis Treatment Demand Share Forecast, 2019-2026
7. Latin America Atopic Dermatitis Treatment Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Atopic Dermatitis Treatment Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Atopic Dermatitis Treatment Demand Share Forecast, 2019-2026
8. Europe Atopic Dermatitis Treatment Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Atopic Dermatitis Treatment Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Atopic Dermatitis Treatment Demand Share Forecast, 2019-2026
9. Asia Pacific Atopic Dermatitis Treatment Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Atopic Dermatitis Treatment Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Atopic Dermatitis Treatment Demand Share Forecast, 2019-2026
10. Middle East & Africa Atopic Dermatitis Treatment Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Atopic Dermatitis Treatment Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Atopic Dermatitis Treatment Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Atopic Dermatitis Treatment Market: Market Share Analysis
  11.2. Atopic Dermatitis Treatment Distributors and Customers
  11.3. Atopic Dermatitis Treatment Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Sanofi SA
     11.4.2. Allergan Plc
     11.4.3. Novartis International AG
     11.4.4. Bristol-Myers Squibb
     11.4.5. Bayer AG
     11.4.6. Meda Pharmaceuticals
     11.4.7. Anacor Pharmaceutical Inc.
     11.4.8. Pfizer&

Methodology

Our Clients

Deloitte
sinopec
General Electric
Honda Motor Co. Ltd.
The John Holland Group
Nestle SA
FedEx Logistics
Pfizer